抽象的

A novel dichoptic home treatment for amblyopia

Oren Yehezkel*, Tamara Wygnanski Jaffe, Michelle Dalton

Patching for the treatment of amblyopia is the current “gold standard” but a new clinical study suggests that using a binocular eye tracking based home treatment system may be as efficacious in appropriate cases. In “an eye tracking based dichoptic home treatment for amblyopia: A multicenter randomized clinical trial” authors Wygnanski-Jaffe, et al. compared NovaSight’s novel CureSight system with traditional patching in children between the ages of 4>9 years who had been diagnosed with anisometropic, small angle strabismic or mixed mechanism amblyopia. The device was an investigational device when this study was performed and received an FDA clearance based on the outcomes of this study (K221375, September 29, 2022).